QVP — Sars-Cov-2 Serology Test Class II

FDA Device Classification

FDA product code QVP covers "Sars-Cov-2 Serology Test", a Class II medical device regulated under 21 CFR 866.3983. Submissions are reviewed by the Microbiology panel. At least 5 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
QVP
Device Class
Class II
Regulation Number
866.3983
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for the diagnosis of acute SARS-CoV-2 infection, nor screening blood, plasma, cells, or tissue donors.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K252280roche diagnosticsElecsys Anti-SARS-CoV-2 SApril 13, 2026
K253839roche diagnosticsElecsys Anti-SARS-CoV-2December 17, 2025
K250768roche diagnosticsElecsys Anti-SARS-CoV-2June 10, 2025
DEN210038ortho-clinical diagnosticsVITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack, VITROS ImmunoMay 5, 2023
DEN210040ortho-clinical diagnosticsVITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack, VITROS ImmuMay 5, 2023